Peroxiredoxin 2 knockdown by RNA interference inhibits the growth of colorectal cancer cells by downregulating Wnt/β-catenin signaling

Cancer Letters

Volumn 343, Issue 2, 2014, Pages 190-199

  Lu, Weidong ^a   Fu, Zhongxue ^a   Wang, Hao ^a   Feng, Jihong ^a   Wei, Jinlai ^a   Guo, Jinbao ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Colorectal cancer; Prdx2; RNA interference; Wnt catenin

Indexed keywords

BETA CATENIN; LENTIVIRUS VECTOR; PEROXIREDOXIN 2; REACTIVE OXYGEN METABOLITE; SHORT HAIRPIN RNA; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER TISSUE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE SILENCING; GENETIC TRANSDUCTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; WESTERN BLOTTING;

MUS MUSCULUS;

APOPTOSIS; COLORECTAL CANCER; PRDX2; RNA INTERFERENCE; WNT/Β-CATENIN;

ANIMALS; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; PEROXIREDOXINS; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WNT SIGNALING PATHWAY;

EID: 84891833726     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.10.002     Document Type: Article

References (53)

1. Jemal A., Bray F., Center M.M., et al. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
2. Halliwell B., Gutteridge J. Free Radicals in Biology and Medicine 1999, Oxford University Press, New York. third ed.
3. Sun A., Chen Y. Oxidative stress and neurodegenerative disorders. J. Biomed. Sci. 1998, 5:401-414.
4. Gius D., Spitz D. Redox signaling in cancer biology. Antioxid. Redox Sign. 2006, 8:1249-1252.
5. Shim S.Y., Kim H.S. Oxidative stress and the antioxidant enzyme in the developing brain. Korean J. Pediatr. 2013, 56(3):107-111.
6. Chae H.Z., Kim I.H., Kim K., Rhee S.G. Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J. Biol. Chem. 1993, 268(22):16815-16821.
7. Kang S.W., Chae H.Z., Seo M.S., et al. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α. J. Biol. Chem. 1998, 273:6297-6302.
8. Järvelä S., Rantala I., Rodriguez A., et al. Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors. BMC Cancer 2010, 10:104.
9. Noh D.Y., Ahn S.J., Lee R.A., et al. Overexpression of peroxiredoxin in human breast cancer. Anticancer Res. 2001, 21:2085-2090.
10. Lomnytska M.I., Becker S., Hellman K., et al. Diagnostic protein marker patterns in squamous cervical cancer. Protemics Clin. Appl. 2010, 4(1):17-31.
11. Kinnula V.L., Lehtonen S., Sormunen R., et al. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J. Pathol. 2002, 196:316-323.
12. Valdman A., Haggarth L., Cheng L., et al. Expression of redox pathway enzymes in human prostatic tissue. Anal. Quant. Cytol. Histol. 2009, 31(6):367-374.
13. Yim M.B., Chae H.Z., Rhee S.G., et al. On the protective mechanism of the thiol-specific antioxidant enzyme against the oxidative damage of biomacro-molecules. J. Biol. Chem. 1994, 269:1621-1626.
14. Netto L.E.S., Chae H.Z.S.W., Kang, et al. Removal of hydrogen peroxide by thiol-specific antioxidant enzyme (TSA) is involved with its antioxidant properties. J. Biol. Chem. 1996, 271:15315-15321.
15. Sarafian T.A., Rajper N., Grigorian B., et al. Cellular antioxidant properties of human natural killer enhancing factor B. Free Radic. Res. 1997, 26:281-289.
16. Lim M.J., Chae H.Z., Rhee S.G., et al. The type II peroxiredoxin gene family of the mouse: molecular structure, expression and evolution. Gene 1998, 216:197-205.
17. Kim H., Lee T.H., Park E.S., et al. Role of peroxideroxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J. Biol. Chem. 2000, 275:18266-18270.
18. Zhang P., Liu B., Kang S.W., et al. Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J. Biol. Chem. 1997, 272:30615-30618.
19. Park S.H., Chung Y.M., Lee Y.S., et al. Antisense of human peroxiredoxin II enhances radiation-induced cell death. Clin. Cancer Res. 2000, 6:4915-4920.
20. Yoo Y.D., Chung Y.M., Park J.K., et al. Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death. Exp. Mol. Med. 2002, 34:273-277.
21. Parmigiani R.B., Xu W.S., Venta-Perez G., et al. HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation. PNAS 2008, 105(28):9633-9638.
22. Wu X.Y., Fu Z.X., Wang X.H. Peroxiredoxins in colorectal neoplasms. Histol. Histopathol. 2010, 25:1297-1303.
23. Cadigan K.M., Nusse R. Wnt signalling: a common theme in animal development. Genes Dev. 1997, 11:3286-3305.
24. Huang S.M.A., Mishina Y.M., Liu S., et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signaling. Nature 2009, 461(7264):614-620.
25. Rowan A.J., Lamlum H., Ilyas M., et al. APC mutations in sporadic colorectal tumors: a mutational ''hotspot" and interdependence of the ''two hits''. Proc. Natl. Acad. Sci. USA 2000, 97:3352-3357.
26. Korinek V., Barker N., Morin P.J., et al. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC -/- colon carcinoma. Science 1997, 275:1784-1787.
27. Clevers H. Wnt/β-catenin signaling in development and disease. Cell 2006, 127:469-480.
28. Polakis P. The oncogenic activation of beta-catenin. Curr. Opin. Genet. Dev. 1999, 9:15-21.
29. Korswagen H.C. Regulation of the Wnt/β-catenin pathway by redox signaling. Dev. Cell 2006, 10(6):687-688.
30. Funato Y., Michiue T., Asashima M., Miki H. The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled. Nat. Cell Biol. 2006, 8:501-508.
31. Almeida M., Han L., Martin-Millan M., et al. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor to forkhead box O-mediated transcription. J. Biol. Chem. 2007, 282:27298-27305.
32. Shin S.Y., Chin B.R., Lee Y.H., Kim J.H. Involvement of glycogen synthase kinase-3beta in hydrogen peroxide-induced suppression of Tcf/Lef-dependent transcriptional activity. Cell. Signal. 2006, 18:601-607.
33. Zhang Z., Wang X., Cheng S., et al. Reactive oxygen species mediate arsenic induced cell transformation and tumorigenesis through Wnt/β-catenin pathway in human colorectal adenocarcinoma DLD1 cells. Toxicol. Appl. Pharmacol. 2011, 256(2):114-121.
34. Hirotsu S., Abe Y., Okada K., et al. Crystal structure of a multifunctional 2-Cys peroxiredoxin heme-binding protein 23 kDa/proliferation-associated gene product. Proc. Natl. Acad. Sci. USA 1999, 96:12333-12338.
35. Szatrowski T.P., Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991, 51:794-798.
36. Lee K.W., Lee D.J., Lee J.Y., et al. Peroxiredoxin II restrains DNA damage-induced death in cancer cells by positively regulating JNK-dependent DNA repair. J. Biol. Chem. 2011, 286(10):8394-8404.
37. Kim K., Yu M., Han S., et al. Expression of human peroxiredoxin isoforms in response to cervical carcinogenesis. Oncol. Rep. 2009, 21(6):1391-1396.
38. ten Berge D., Brouwer A., Korving J., et al. Prx1 and Prx2 are upstream regulators of sonic hedgehog and control cell proliferation during mandibular arch morphogenesis. Development 2001, 128:2929-2938.
39. Yan Y., Sabharwal P., Rao M., Sockanathan S. The antioxidant enzyme Prdx1 controls neuronal differentiation by thiol-redox-dependent activation of GDE2. Cell 2009, 138:1209-1221.
40. Stresing V., Baltziskueta E., Rubio N., et al. Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs. Oncogene 2013, 32(6):724-735.
41. Qu D., Rashidian J., Mount M.P., et al. Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. Neuron 2007, 55:37-52.
42. E. Cadenas, K.J.A. Davies (2000) Mitochondrial free radical generation, oxidative stress, and aging, Free Radic. Biol. Med. 29 (3) (2013) 222-230.
43. Chen J., Kinter M., Shank S., et al. Dysfunction of Nrf-2 in CF epithelia leads to excess intracellular H2O2 and inflammatory cytokine production. PLoS One 2008, 3(10):e3367.
44. Maynard S., Schurman S.H., Harboe C., de Souza-Pinto N.C., Bohr V.A. Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis 2009, 30(1):2-10.
45. Zhao F., Wang Q. The protective effect of peroxiredoxin II on oxidative stress induced apoptosis in pancreatic β-cells. Cell Biosci. 2012, 2(1):22.
46. Yang S., Luo A., Hao X., et al. Peroxiredoxin 2 inhibits granulosa cell apoptosis during follicle atresia through the NFKB pathway in mice. Bio. Reprod. 2011, 84(6):1182-1189.
47. Paez D., Gerger A., Zhang W., et al. Association of common gene variants in the WNT/β-catenin pathway with colon cancer recurrence. Pharmacogenomics J. 2013, 1-9.
48. Curtin J.C. Novel drug discovery opportunities for colorectal cancer. Expert Opin. Drug Discov. 2013, 8(9):1153-1164.
49. Pandurangan A.K. Potential targets for prevention of colorectal cancer: a focus on PI3K/Akt/mTOR and Wnt pathways. Asian Pacific J. Cancer Prev. 2013, 14(4):2201-2205.
50. Ashokkumar P., Sudhandiran G. Luteolin inhibits cell proliferation during azoxymethane-induced experimental colon carcinogenesis via Wnt/β-catenin pathway. Invest. New Drugs 2011, 29:273-284.
51. Takahashi-Yanaga F., Sasaguri T. The Wnt/β-Catenin signaling pathway as a target in drug discovery. J. Pharmacol. Sci. 2007, 104(4):293-302.
52. Gao Y., Liu Z., Zhang X., et al. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells. Cancer Lett. 2013, 336(1):231-239.
53. Lim Y.S., Cha M.K., Kim H.K., et al. Removals of hydrogen peroxide and hydroxyl radical by thiol-specific antioxidant protein as a possible role in vivo. Biochem. Biophys. Res. Commun. 1993, 192:273-280.